Authors:
Bold, RJ
Charnsangavej, C
Cleary, KR
Jennings, M
Madary, A
Leach, SD
Abbruzzese, JL
Pisters, PWT
Lee, JE
Evans, DB
Citation: Rj. Bold et al., Major vascular resection as part of pancreaticoduodenectomy for cancer: Radiologic, intraoperative, and pathologic analysis, J GASTRO S, 3(3), 1999, pp. 233-243
Authors:
Bold, RJ
Hess, KR
Pearson, AS
Grau, AM
Sinicrope, FA
Jennings, M
McConkey, DJ
Bucana, CD
Cleary, KR
Hallin, PA
Chiao, PJ
Abbruzzese, JL
Evans, DB
Citation: Rj. Bold et al., Prognostic factors in resectable pancreatic cancer: p53 and Bcl-2, J GASTRO S, 3(3), 1999, pp. 263-276
Citation: Rj. Bold et al., Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content, ANN SURG O, 6(3), 1999, pp. 279-285
Authors:
Pearlstone, DB
Pisters, PWT
Bold, RJ
Feig, BW
Hunt, KK
Yasko, AW
Patel, S
Pollack, A
Benjamin, RS
Pollock, RE
Citation: Db. Pearlstone et al., Patterns of recurrence in extremity liposarcoma - Implications for stagingand follow-up, CANCER, 85(1), 1999, pp. 85-92
Authors:
Bouvet, M
Bold, RJ
Lee, J
Evans, DB
Abbruzzese, JL
Chiao, PJ
McConkey, DJ
Chandra, J
Chada, S
Fang, BL
Roth, JA
Citation: M. Bouvet et al., Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer, ANN SURG O, 5(8), 1998, pp. 681-688
Citation: Rj. Bold et al., Bombesin stimulates in vitro growth of human breast cancer independent of estrogen receptors status, ANTICANC R, 18(6A), 1998, pp. 4051-4056